Health Economics and Outcomes Research

The use of established methods and innovative tailored solutions in our HEOR, for the pharmaceutical, biotech and medical device clients, generate HEOR evidence, meet specific HTA challenges, support market access, and reinforce arguments for product reimbursement. Development of global HEOR strategy, including strategic roadmaps and evidence generation for product planning, and advisory boards to validate the strategy and regulatory support for FDA and EMA can be accelerated.

Our Expertise

• Early-Stage Economic Models and Cross-Indication Platforms
• Evidence Publications Management Across the Product Lifecycle
• Global Cost-Effectiveness Models and Country-Specific Model Adaptations
• Economic Impact of Treatments, Diseases and Conditions
• Development of Curated Analytic Datasets & Charts for Longitudinal Analysis
• Demonstrate Clinical and Economical Value of Innovations